Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TACR1 | P25103 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | AGXT | P21549 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1227815 | 0.89 | MAOB (0.48) | ALDH1A1LMNAMMP2 | |
| SCHEMBL5555166 | 0.84 | TSHR (0.45) | TSHRTACR1ALDH1A1IDO1TAAR1 | |
| SCHEMBL13279978 | 0.82 | ALDH1A1 (0.50) | TSHRTACR1ALDH1A1TAAR1 | |
| SCHEMBL22611647 | 0.82 | IDO1 (0.41) | IDO1AGXTLMNA | |
| SCHEMBL11021009 | 0.82 | TACR1 (0.30) | TSHRTACR1ALDH1A1 | |
| SCHEMBL11355291 | 0.82 | TACR1 (0.43) | TSHRTACR1ALDH1A1 | |
| SCHEMBL28176655 | 0.82 | TACR1 (0.43) | TSHRTACR1ALDH1A1 | |
| SCHEMBL21082398 | 0.82 | TACR1 (0.43) | TSHRTACR1ALDH1A1 | |
| SCHEMBL10371092 | 0.81 | TSHR (0.54) | TSHRTACR1ALDH1A1IDO1TAAR1 | |
| SCHEMBL5575731 | 0.81 | TSHR (0.45) | TSHRTACR1ALDH1A1IDO1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022225312-A1 | OXAZOLIDINONE DERIVATIVE AND HERBICIDAL COMPOSITION COMPRISING THE COMPOUND | 한국화학연구원 | 2022-10-27 | — | — | WO | disclosed |
| EP-4029870-A1 | TRICYCLIC BENZOXABOROLE COMPOUNDS AND USES THEREOF | GlaxoSmithKline Intellectual Property (No.2) Limited (GB) | 2022-07-20 | — | — | EP | disclosed |
| CN-110003253-B | Tricyclic benzoxaborole compounds and uses thereof | 葛兰素史克知识产权第二有限公司 | 2022-03-18 | — | — | CN | disclosed |
| EP-3350170-B1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2022-01-26 | — | — | EP | disclosed |
| EP-3030519-B1 | TRICYCLIC BENZOXABOROLE COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE IP NO 2 LTD (GB) | 2022-01-05 | — | — | EP | disclosed |
| US-11214582-B2 | 4-substituted benzoxaborole compounds and uses thereof | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2022-01-04 | — | — | US | disclosed |
| US-11214582-B2 | 4-substituted benzoxaborole compounds and uses thereof | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2022-01-04 | — | — | US | disclosed |
| CN-108602776-B | Heteroaryl compounds as IRAK inhibitors and uses thereof | 默克专利有限公司 | 2021-12-03 | — | — | CN | disclosed |
| EP-3350177-B1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2021-07-07 | — | — | EP | disclosed |
| US-20210053996-A1 | 4-Substituted Benzoxaborole Compounds and Uses Thereof | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2021-02-25 | — | — | US | disclosed |
| US-7582355-B2 | Optical unit using plastic lenses | FUJIFILM CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-7563832-B2 | Photocurable resin composition and resin composition for plastics comprising the same | MITSUI CHEMICALS, INC. (JP) | 2009-07-21 | — | — | US | disclosed |
| CN-100347236-C | Photocurable resin composition and resin composition for plastics comprising the same | MITSUI CHEMICALS INC (JP) | 2007-11-07 | — | — | CN | disclosed |
| US-20070037896-A1 | polymerizable resin composition comprises an epoxy compound, a photo cation polymerization initiator, and a photo radical polymerization initiator; excellent in curing properties and corrosion resistance with less resin coloration and less cure shrinkage; surface protective material for optical disks | MITSUI CHEMICALS, INC. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-20060046065-A1 | Optical unit using plastic lenses | FUJI PHOTO FILM CO., LTD. | 2006-03-02 | — | — | US | disclosed |
| EP-1630189-A1 | CATIONICALLY PHOTOPOLYMERIZABLE RESIN COMPOSITION AND OPTICAL DISK SURFACE PROTECTION MATERIAL | Mitsui Chemicals, Inc. (JP) | 2006-03-01 | — | — | EP | disclosed |
| EP-1630215-A2 | Photocurable resin composition and resin composition for plastics comprising the same | Mitsui Chemicals, Inc. (JP) | 2006-03-01 | — | — | EP | disclosed |
| US-20060020051-A1 | Photocurable resin composition and resin composition for plastics comprising the same | MITSUI CHEMICALS, INC. (JP) | 2006-01-26 | — | — | US | disclosed |
| CN-1724587-A | Photocurable resin composition and resin composition for plastics comprising the same | MITSUI CHEMICALS INC (JP) | 2006-01-25 | — | — | CN | disclosed |
| US-4259236-A | COLORFAST RED SHADES ON POLYESTERS | CIBA-GEIGY CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210053996-A1 | 4-Substituted Benzoxaborole Compounds and Uses Thereof | BRI3BP, CBR3, CYCS | TSHR 2375/4885TACR1 3965/4885ALDH1A1 3139/4885 |
| US-11214582-B2 | 4-substituted benzoxaborole compounds and uses thereof | BRI3BP, CBR3, CYCS | TSHR 2375/4885TACR1 3965/4885ALDH1A1 3139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.